FUNDC2 contributes to hypertensive vascular remodeling by regulating mitochondrial dynamics and ferroptosis in

Yuanyuan Jin1, Tingting Song1, Tingting Jiang1

  • 1Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.

Abstract

Insights

Increased FUNDC2 in perivascular adipose tissue (PVAT) may drive hypertensive vascular remodeling by affecting mitochondrial dynamics and adipokine secretion. This research highlights FUNDC2 as a potential therapeutic target for hypertension.

Area of Science:

  • Cardiovascular Biology
  • Metabolic Research
  • Molecular Mechanisms of Disease

Background:

  • Perivascular adipose tissue (PVAT) plays a critical role in the development of vascular remodeling associated with hypertension.
  • Understanding the molecular mechanisms by which PVAT influences hypertensive vascular remodeling is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the specific molecular mechanisms of PVAT involvement in the onset and progression of hypertensive vascular remodeling.
  • To identify key proteins and pathways dysregulated in PVAT during hypertension.

Main Methods:

  • Proteomic analysis of thoracic aorta PVAT from spontaneously hypertensive rats (SHRs) and Wistar-Kyoto (WKY) rats.
  • Validation of differential protein expression using western blotting, immunohistochemistry, and transmission electron microscopy (TEM).
  • In vitro studies involving FUNDC2 knockdown in 3T3-L1 adipocytes and subsequent analysis of mitochondrial dynamics, ferroptosis, adipokine secretion, and vascular smooth muscle cell (VSMC) behavior.

Main Results:

  • Proteomics identified significantly upregulated FUNDC2 in the PVAT of SHRs compared to WKY rats.
  • Mitochondrial dynamics and ferroptosis-related proteins were significantly altered in SHR PVAT.
  • FUNDC2 knockdown in adipocytes reversed changes in mitochondrial dynamics, ferroptosis markers, and adipokine secretion, impacting VSMC phenotype and migration.

Conclusions:

  • Elevated FUNDC2 expression in PVAT may induce PVAT dysfunction and aberrant adipokine secretion.
  • These alterations, linked to mitochondrial dynamics and ferroptosis in PVAT adipocytes, contribute to hypertensive vascular remodeling.
  • FUNDC2 emerges as a potential molecular target for mitigating hypertensive vascular remodeling.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
663
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
700
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.3K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
16.5K